Parker R B, Williams C L, Laizure S C, Lima J J
University of Tennessee-Memphis, Department of Clinical Pharmacy, USA.
J Pharmacol Exp Ther. 1995 Nov;275(2):605-10.
The free (unbound) drug in serum is an important determinant of pharmacologic response. The present study was performed to more completely identify and evaluate factors affecting cocaine binding to human serum proteins. Protein binding was determined by ultrafiltration with [3H] cocaine. Cocaine binding parameters in serum from eight healthy volunteers were determined over a concentration range of 0.003 to 300 microM (0.001-100 micrograms/ml) and indicated cocaine binds to two classes of independent binding sites; one with high affinity [association constant (Ka) = 0.42 +/- 0.09 microM-1] and low capacity (N1 = 12.3 +/- 2.9 microM) and one with low affinity and high capacity (gamma = 0.41 +/- 0.05). Binding was concentration dependent with free fraction increasing from 0.16 +/- 0.05 to 0.68 +/- 0.02 over this concentration range. The binding capacity was significantly correlated with alpha-1-acid glycoprotein (AAG) concentration (r2 = 0.71, P = .0009). Binding studies were performed using AAG and human serum albumin (HSA) alone and together in phosphate buffer to determine the specific proteins responsible for cocaine binding. These studies revealed the binding of cocaine to AAG is potentiated by the presence of HSA as Ka for the first binding site increased from 0.08 microM-1 with AAG alone to 0.46 microM-1 with AAG combined with HSA 4 g/dl. Binding parameter estimates and cocaine free fraction in human serum and AAG 75 mg/dl plus HSA 4 g/dl in phosphate buffer were similar indicating that AAG and HSA are the principal binding proteins in serum.(ABSTRACT TRUNCATED AT 250 WORDS)
血清中的游离(未结合)药物是药理反应的重要决定因素。本研究旨在更全面地鉴定和评估影响可卡因与人血清蛋白结合的因素。通过用[3H]可卡因进行超滤来测定蛋白结合情况。在0.003至300微摩尔/升(0.001 - 100微克/毫升)的浓度范围内测定了8名健康志愿者血清中的可卡因结合参数,结果表明可卡因与两类独立的结合位点结合;一类具有高亲和力[缔合常数(Ka)= 0.42 ± 0.09微摩尔-1]和低容量(N1 = 12.3 ± 2.9微摩尔),另一类具有低亲和力和高容量(γ = 0.41 ± 0.05)。结合呈浓度依赖性,在此浓度范围内游离分数从0.16 ± 0.05增加到0.68 ± 0.02。结合容量与α-1-酸性糖蛋白(AAG)浓度显著相关(r2 = 0.71,P = 0.0009)。在磷酸盐缓冲液中单独及共同使用AAG和人血清白蛋白(HSA)进行结合研究,以确定负责可卡因结合的特定蛋白质。这些研究表明,由于第一个结合位点的Ka从单独使用AAG时的0.08微摩尔-1增加到与4克/分升HSA联合使用AAG时的0.46微摩尔-1,HSA的存在增强了可卡因与AAG的结合。人血清以及磷酸盐缓冲液中75毫克/分升AAG加4克/分升HSA中的结合参数估计值和可卡因游离分数相似,表明AAG和HSA是血清中的主要结合蛋白。(摘要截短至250字)